✦ LIBER ✦

A Randomized Trial of Ustekinumab, a Human Interleukin-12/23 Monoclonal Antibody, in Patients With Moderate-to-Severe Crohn's Disease

✍ Scribed by William J. Sandborn; Brian G. Feagan; Richard N. Fedorak; Ellen Scherl; Mark R. Fleisher; Seymour Katz; Jewel Johanns; Marion Blank; Paul Rutgeerts

Book ID: 119760524
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 648 KB
Volume: 135
Category: Article
ISSN: 0016-5085
DOI: 10.1053/j.gastro.2008.07.014

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T1132 Pharmacokinetics and Exposure-Resp

T1132 Pharmacokinetics and Exposure-Response Relationship of Ustekinumab, a Human Monoclonal Antibody to Interleukin 12/23, in Patients with Moderate-to-Severe Crohn's Disease

✍ Fasanmade, Adedigbo A.; Adedokun, Omoniyi J.; Johanns, Jewel R.; Zhou, Honghui; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 117 KB

A randomized, placebo-controlled trial o

A randomized, placebo-controlled trial of CDP571, a humanized monoclonal antibody to TNF-α, in patients with moderate to severe Crohn's disease

✍ William J. Sandborn; Brian Feagan; Graham Radford-Smith; Agota Kovacs; Robert En 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

A Multicenter, Randomized, Double-Blind,

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase2b Study of Ustekinumab, a Human Monoclonal Antibody to IL-12/23p40, in Patients With Moderately to Severely Active Crohn's Disease: Results Through Week 22 From the Certifi Trial

✍ William J. Sandborn; Christopher Gasink; Long-Long Gao; Marion Blank; Jewel Joha 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 145 KB

A pilot randomized trial of a human anti

A pilot randomized trial of a human anti-interleukin-6 receptor monoclonal antibody in active Crohn’s disease

✍ Hiroaki Ito; Masakazu Takazoe; Yoshihiro Fukuda; Toshifumi Hibi; Kazuo Kusugami; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 249 KB

A randomized controlled trial of CDP571,

A randomized controlled trial of CDP571, a humanized antibody to TNFA, in moderately to severely active Crohn's disease

✍ Sanborn, William J.; Targan, Stephan R.; Hanauer, Stephan B.; Present, Daniel H. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 165 KB

A phase 1/2A Trial of STA 5326, an oral

A phase 1/2A Trial of STA 5326, an oral interleukin-12/23 inhibitor, in patients with active moderate to severe Crohn's disease

✍ Robert Burakoff; Charles F. Barish; Dennis Riff; Ronald Pruitt; William Y. Chey; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 258 KB